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TIVE (MC) AND REDUCED INTENSITY CONDITIONING (RIC) REGIMENS
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Background: Long term survivors of allogeneic HSCT (aHSCT)
may experience significant psychosocial distress. Although factors
predicting increased distress have been reported, the influence of
conditioning intensity has not been explored.
Purpose: This analysis compares the psychosocial (PS) adjust-
ment of long term survivors who received RIC (n 5 43) or MC (n
5 77) regimens and examines predictors of PS adjustment and its re-
lationship with health-related quality of life (HRQL).
Methods: Cross-sectional data were drawn from an ongoing lon-
gitudinal study. Measures included the Psychosocial Adjustment to
Illness Scale (PAIS), the Rotterdam Symptom Checklist-physical
(RSCL-P) and the Functional Assessment of Cancer Therapy – Gen-
eral (FACT-G). Data were analyzed using descriptive statistics, cor-
relation and regression analyses.
Results: Subjects (N 5 120) were a median of 62 months from
aHSCT (range 34–156), predominantly male (59%), married
(63%), and had an ECOG status of 0 (86%). Mean scores for PS ad-
justment did not differ between the RIC (27.662.56) and MC
(26.161.82) groups (t5 4.93, p5 0.62). Age, gender, marital status,
education, employment, transplant conditioning intensity, perfor-
mance status and physical symptom distress explained 50.5% of
the variability in PAIS scores (F 5 9.30, p\0.01). Being unmarried
(b 520.169, p 5 0.044) and experiencing greater physical symptom
distress (b 5 0.609, p\0.001) independently predicted poor adjust-
ment. Poor PS adjustment was strongly associated with poor
HRQL (r520.78, p\0.001). Survivors (n5 29; 24%) with poor ad-
justment (PAIS T-score $62) reported the greatest difficulties with
family (immediate and extended) issues, sexual relationships and
psychological distress.
Conclusion: Understanding the factors that predict poor PS
adjustment in survivors of aHSCT guides assessment strategies in-
cluding approaches to systematically assess and manage distressing
symptoms. Studies to develop and test educational and counseling
interventions that optimize individual and family functioning,
including sexual relationships, in transplant recipients are
warranted.
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IMPLICATIONS FOR NURSES AND THE SUPPORTIVE CARE NEEDS FOR
CHILDREN UNDERGOING REDUCED INTENSITY CONDITIONING (RIC)
ALLOGENEIC STEM CELL TRANSPLANTATION (RIC-ALLOSCT)
Barrell, C.1, Dietzen, D.1, Shonfeld, T.1, Pinchefsky, S.1, Satwani, P.2
1Morgan Stanley Children’s Hospital of New York Presbyterian, New
York, NY; 2Columbia University, New York, NY
Allogeneic hematopoietic stem transplant (AlloSCT) is a cura-
tive option for many children with malignant and non-malignant
disorders. However, myeloablative AlloSCTs are associated with
20–40% non-relapse related mortality (NRM) in first 100 days
post AlloSCT (Satwani/Cairo et al, BBMT 2005, PBC 2007).
The morbidity and mortality associated with AlloSCT often resultin an increase in length and complexity of nursing care. However,
RIC-SCT may potentially reduce toxicities and lead to a reduction
in supportive care needs associated with an increase in nursing
care; including reduction of blood products, antibiotics, TPN,
and narcotics. There is limited data on the toxicities of RIC-Al-
loSCT in children and the impact on their nursing needs. We eval-
uated the toxicities and supportive care measures during the
conditioning regimen and 30 days post transplant required in 43
children who underwent a RIC-AlloSCT between January 2004-
March 2008 for either a malignant (n5 23) or non-malignant dis-
ease (n 5 21): Median age 10yrs (0.3- 22yrs), UCB (n 5 17),
MFD (n 5 20), MUD (n 5 6). Average risk patients (n 5 41),
poor risk (n 5 2).
Regimens: Busulfan(6.4–8mg/kg)1Fludarabine(150–180mg/m2)
6 ATG(8mg/m2) (n 5 22); Cyclophospamide(60mg/kg)1Fludara-
bine 1 (150mg/m2) 6 ATG(8mg/m2) (n 5 10); Busulfan (12.8–
16mg/kg)1Fludarabine (150mg/m2)1 Alemtuzumab (54mg/ m2)
(n 5 11). Median time to neutrophil and platelet recovery was
14.5 (8–38) and 32.5 (10–99) days, respectively. Median number of
platelet and PRBC tranfusions was 6(0–32) and 3(0–11), respectively.
The incidence of aGVHD (Gr II-IV) was 33%. One patient had pri-
mary graft failure and the incidence of VOD was zero. Median drop
in estimated CrCL from pre transplant to 30 days post was 40% (0–
68). The median highest grade of mucositis was 1 (0–3) with median
number of days on TPN 0 (0–38) and median number of days requir-
ing a PCA 0 (0–30). The median number of days with fever 3 (0–21)
and the median number of infections per patient 1 (0–2) of which 2
patients required line removal. Three patients required ICU
transfer. Day 100 NRM was 2%.
Conclusions: RIC-AlloSCT is safe, well tolerated, and associated
with significantly lower NRM. We hypothesize RIC will demon-
strate a decrease in nursing time and complexity of care. Therefore,
we are in the process of collecting data on our patients who had
a myeloablative AlloSCT to compare the incidence of various
toxicities and subsequent nursing supportive care needs to our
RIC-AlloSCT experience.80
EASING THE TBI EXPERIENCE IN THE PRE-SCHOOL PATIENT
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Pediatric patients in the pre-school age group can pose
unique challenges for their care team and caregivers when un-
dergoing preparative therapy for transplantation. This is espe-
cially true when total body irradiation (TBI) is included in
the preparative regimen. Typically, TBI in the pre-school pa-
tient involves the use of general anesthesia (GA) to ensure
proper positioning, cooperation, and general patient safety.
TBI treatments at our center are given outpatient in BID frac-
tions, over 4–5 days. A consult with anesthesia is included in the
pre-transplant work-up, and the caregiver is given detailed in-
formation about keeping the child NPO for 4–6 hours, not
only once, but twice daily. As a result, many of these children
need daily IV fluids in our clinic. To address these challenges,
our center implemented a program designed to identify pre-
schoolers as potential candidates to receive their TBI treat-
ments without GA. Initial discussions between the transplant
nurse coordinator and the caregiver provide education regard-
ing TBI. The patient is then scheduled for a consultation
with the pediatric radiation oncologist. Discussion includes
the option for the patient to have a ‘‘practice’’ TBI session.
We have found this session key in identifying children who
could receive TBI without GA. The practice session involves
collaboration of skilled radiation therapy technicians and Child
Life Specialists. Age appropriate techniques are used to help
the patient practice their treatment position. The child is
taught how and why the legs and forehead may be taped to
help hold them steady. Children have the choice of watching
a favorite video, or talking to their caregiver through in inter-
com system. The treatment door is closed for 5–7 minutes, sim-
ulating an actual treatment. If the session is successful, the
